Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)-Reference-Cited by-同舟云学术

Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Published:2018-02-09 Issue:5 Volume:20 Page:731-732an
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Dan Gheorghe-Andrei¹,Martinez-Rubio Antoni²,Agewall Stefan³⁴,Boriani Giuseppe⁵,Borggrefe Martin⁶,Gaita Fiorenzo⁷,van Gelder Isabelle⁸,Gorenek Bulent⁹,Kaski Juan Carlos¹⁰,Kjeldsen Keld¹¹¹²,Lip Gregory Y H¹³¹⁴,Merkely Bela¹⁵,Okumura Ken¹⁶,Piccini Jonathan P¹⁷,Potpara Tatjana¹⁸,Poulsen Birgitte Klindt¹⁹,Saba Magdi¹⁰,Savelieva Irina¹⁰,Tamargo Juan L²⁰,Wolpert Christian²¹,Sticherling Christian²²,Ehrlich Joachim R²³,Schilling Richard²⁴,Pavlovic Nikola²⁵,De Potter Tom²⁶,Lubinski Andrzej²⁷,Svendsen Jesper Hastrup²⁸,Ching Keong²⁹,Sapp John Lewis³⁰,Chen-Scarabelli Carol³¹,Martinez Felipe³²,

Affiliation:

1. Colentina University Hospital, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania

2. University Hospital of Sabadell (University Autonoma of Barcelona), Plaça Cívica, Campus de la UAB, Barcelona, Spain

3. Oslo University Hospital Ullevål, Norway

4. Institute of Clinical Sciences, University of Oslo, Søsterhjemmet, Oslo, Norway

5. Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy

6. Universitaetsmedizin Mannheim, Medizinische Klinik, Mannheim, Germany

7. Department of Medical Sciences, University of Turin, Citta' della Salute e della Scienza Hospital, Turin, Italy

8. Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

9. Department of Cardiology, Eskisehir Osmangazi University, Büyükdere Mahallesi, Odunpazarı/Eskişehir, Turkey

10. Molecular and Clinical Sciences Research Institute, St. George’s, University of London, London, UK

11. Copenhagen University Hospital (Holbæk Hospital), Holbæk, Institute for Clinical Medicine, Copenhagen University, Copenhagen, Denmark

12. Department of Health Science and Technology, Aalborg University, Aalborg, Denmark

13. Institute of Cardiovascular Sciences, University of Birmingham, Centre For Cardiovascular Sciences, City Hospital, Birmingham, UK

14. Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark

15. Heart and Vascular Center, Semmelweis University, Budapest, Hungary

16. Saiseikai Akumamoto Hospital, Kumamoto, Japan

17. Department of Medicine, Duke Clinical Research Institute, Durham, USA

18. School of Medicine, Belgrade University; Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia

19. Aarhus University Hospital, Klinisk Farmakologisk Enhed, Aalborg, Denmark

20. Department of Pharmacology, School of Medicine, Universidad Complutense Madrid, Madrid, Spain

21. Department of Medicine - Cardiology, Klinikum Ludwigsburg, Ludwigsburg, Germany

22. Department of Cardiology, University Hospital Basel, Basel, Switzerland

23. Medizinische Klinik I-Kardiologie, Angiologie, Pneumologie, Wiesbaden, Germany

24. Barts Heart Centre, Trustee Arrhythmia Alliance and Atrial Fibrillation Association, London, UK

25. Department of Cardiology, University Hospital Centre Sestre milosrdnice, Croatia

26. Cardiology Department, Olv Aalst, Belgium

27. Uniwersytet Medyczny w Łodzi, Kierownik Kliniki Kardiologii Interwencyjnej, i Zaburzeń Rytmu Serca, Kierownik Katedry Chorób Wewnętrznych i Kardiologii, Uniwersytecki Szpital Kliniczny im WAM-Centralny Szpital Weteranów, Poland

28. Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

29. Department of Cardiology, National Heart Centre Singapore, Singapore

30. QEII Health Sciences Center, Canada

31. Division of Cardiology, Richmond VA Medical Center, Richmond, USA

32. Instituto DAMIC/Fundacion Rusculleda, Universidad Nacional de Córdoba, Córdoba, Argentina

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/20/5/731/24794585/eux373.pdf

Reference254 articles.

1. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease;Allen LaPointe;Am J Cardiol,2015

2. Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation;Allen LaPointe;Am Heart J,2013

3. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction;The Cardiac Arrhythmia Suppression Trial (CAST) Investigators;N Engl J Med,1989

4. Atrial fibrillation-the final frontier;Govindan;J Cardiovasc Pharmacol Ther,2010

5. Changing the Paradigm to Understand and Manage Atrial Fibrillation

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic kidney disease and atrial fibrillation: approaches to the choice of antiarrhythmic therapy;The Siberian Journal of Clinical and Experimental Medicine;2024-01-11

2. Antiarrhythmic drugs for atrial fibrillation in the outpatient setting;Minerva Medica;2024-01

3. SOP – Kardioversion und Antikoagulationsmanagement;Kardiologie up2date;2023-12

4. Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study;American Journal of Physiology-Heart and Circulatory Physiology;2023-11-01

5. Number of ventricular premature beats and other causes of cardiomyopathy associated with arrhythmia: case reports;Journal of Arrhythmology;2023-10-25